Janssen Pharmaceuticals, Inc. v. A.Y.

U.S. Supreme Court

Question(s) Presented

Whether federal law preempts state-law claims that a manufacturer failed to provide adequate warnings relating to the off-label use of their products, where federal law bars the manufacturer from unilaterally altering its labeling to provide such warnings.

Tab Group